The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial

✍ Scribed by A. Rafnsson; F. Böhm; M. Settergren; A. Gonon; K. Brismar; J. Pernow

• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 214 KB
• Volume: 55
• Category: Article
• ISSN: 0012-186X
• DOI: 10.1007/s00125-011-2415-y